Anticonvulsant pharmacodynamics and disposition of triazolam in rats

Journal of Pharmaceutical Sciences

Volumn 85, Issue 9, 1996, Pages 999-1004

  Gaudreault, Jacques ^a   Varin, France ^a   Pollack, Gary M ^b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIAZOLAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG CLEARANCE; DRUG DISPOSITION; DRUG POTENCY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MUSCLE RELAXATION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEDATION; SEIZURE; TRANQUILIZING ACTIVITY;

EID: 0029781581     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9503183     Document Type: Article

References (48)

1. Hollister, L. E.; Müller-Oelinghausen, B.; Rickels, K.; Shader, R. I. J. Clin. Psychopharmacol. 1993, 13(6), Suppl. 1, 1s-169s.
2. Gupta, S. K.; Ellinwood, E. H.; Nikaido, A. M.; Heatherly, D. G. Pharm. Res. 1990, 7, 570-576.
3. Kroboth, P. D.; Smith, R. B.; Van Thiel, D. H.; Juhl, R. P. J. Clin. Pharmacol. 1987, 27, 555-560.
4. Kroboth, P. D.; Smith, R. B.; Rosanske, T.; Hamilton, J. M.; McAuley, J. W.; Kroboth, F. J.; Juhl, R. P. Pharm. Res. 1986, 3, 110s.
5. Vanderveen, R. P.; Jirak, J. L.; Peters, G. R.; Cox, S. R.; Bombardt, P. A. Clin. Pharmacol. 1991, 10, 539-543.
6. Eberts, F. S.; Philopoulos, Y.; Reineke, L. M.; Vliek, R. W. Clin. Pharmacol. Ther. 1981, 29(1), 81-93.
7. Garzone, P. D.; Kroboth, P. D. Clin. Pharmacokinet. 1989, 16, 337-364.
8. Dehlin, O.; Björnson, G.; Börjesson, L.; Abrahamsson, L.; Smith, R. B. Eur. J. Clin. Pharmacol. 1983, 25, 91-94.
9. Sethy, V. H.; Harris, D. W. J. Pharm. Pharmacol. 1982, 34, 115-116.
10. Gall, M.; Kamdar, B. V.; Collins, R. J. J. Med. Chem. 1978, 21(12), 1290-1293.
11. Roth, T.; Tietz, E. I.; Kramer, M.; Kaffeman, M. J. Intern. Med. Res. 1979, 7, 583-587.
12. Kroboth, P. D.; Juhl, R. P. Drug. Intell. Clin. Pharm. 1983, 17, 495-500.
13. Kitagawa, H.; Esumi, Y.; Kurosawa, S.; Sekine, S.; Yokoshima, T. Xenobiotica 1979, 9, 415-428.
14. Kitagawa, H.; Esumi, Y.; Kurosawa, S.; Sekine, S.; Yokoshima, T. Xenobiotica 1979, 9, 429-439.
15. Bruni, G.; Di Simplicio, P.; Urso, R.; Segre, G. Int. J. Clin. Pharmacol. Res. 1990, 10, 217-221.
16. Gonzalez, J. P.; McCulloch, A. J.; Nicholls, P. J.; Sewell, R. D. E.; Tekle, A. Alcohol 1984, 19, 325-332.
17. Bellantuono, C.; Reggi, G.; Tognoni, G.; Garattini, S. Drugs. 1980, 19, 195-219.
18. Novack, G. D.; Owenburg, K. M. Electroencephalograph Clin. Neurophysiol. 1984, 57, 277-288.
19. Gibaldi, M.; Perrier, D. Pharmacokinetics; Marcel Dekker: New York, 1982; pp 409-417.
20. Lister, R. G.; File, S. E.; Greenblatt, D. J. Life Sci. 1983, 32, 2033-2040.
21. Loscher, W.; Schmidt, D. Epilepsy Res. 1988, 2, 145-181.
22. Kupferberg, H. J. Current and future trends in anticonvulsant, anxiety and stroke therapy; Meldrum, B. S., Williams, M., Eds.; Wiley-Liss: New York, 1990; pp 113-130.
23. Porter, R. J. Epilepsy and GABA receptor agonists basic and therapeutic research; Bartholini, G.; Bossi, L.; Lloyd, K. G.; Morselli, P. L., Eds.; Raven: New York, 1985; pp 449-452.
24. Porter, R. J. Jpn. J. Psychiatr. Neurol. 1983, 47, 145-162.
25. Ramanjaneyulu, R.; Ticku, M. Eur. J. Pharmacol. 1984, 98, 337-345.
26. Swinyard, E. A. Epilepsia 1969, 10, 107-119.
27. Pollack, G. M.; Shen, D. D. J. Pharmacol. Meth. 1985, 13, 135-146.
28. Ramzan, I. M.; Levy, G. J. Pharmacol. Exp. Ther. 1985, 234(3), 624-628.
29. Caccia, S.; Fong, M. H.; Urso, R. J. Pharm. Pharmacol. 1985, 37, 567-570.
30. Takàcs-Novak, K.; Oelschläger, H.; Budvári-Bárány, Z.; Szász, G. Pharmazie 1992, 47, 587-592.
31. Klockowski, P. M.; Levy, G. J. Chromatogr. 1987, 422, 334-339.
32. Adams, W. J. Anal. Lett. 1979, 12(B6), 657-671.
33. Gibaldi, M.; Perrier, D. Pharmacokinetics; Marcel Dekker: New York, 1982; pp 45-111.
34. Smith, R. B.; Kroboth, P. D.; Varner, P. D. J. Clin. Pharmacol. 1987, 27, 971-979.
35. Eberts, F. S. Drug. Metab. Dispos. 1977, 5(6), 547-555.
36. Scavone, J. M.; Friedman, H.; Greenblatt, D. J.; Shader, R. I. Arzneim.-Forsch. 1987, 37, 2-6.
37. Friedman, H.; Abernethy. D. R.; Greenblatt, D. J.; Shader, R. I. Psychopharmacology 1986, 88, 267-270.
38. Miller, L. G.; Greenblatt, D. J.; Abernethy, D. R.; Friedman, H.; Luu, M. D.; Paul, S. M.; Shader, R. I. Psychopharmacology 1988, 94, 386-391.
39. Dingemanse, J.; Sollie, F. A. E.; Breimer, D. D.; Danhof, M. J. Pharmacokinet. Biopharm. 1988, 16, 203-228.
40. Esplin, D. W.; Woodbury, D. M. J. Pharmacol. Exp. Ther. 1956, 118, 129-138.
41. Halohen, T.; Pitkanen, A.; Partanen, J.; Hyttinen, J. M.; Riekkinen, P. J. Comp. Biochem. Physiol. C 1992, 101, 21-25.
42. Dingemanse, J.; Van Bree, J. B. M. M.; Danhof, M. J. Pharmacol. Exp. Ther. 1989, 249, 601-608.
43. Mandema, J. W.; Sansom, L. N.; Dios-Vietez, M. C.; Hollander-Jansen, M.; Danhof, M. J. Pharmacol. Exp. Ther. 1991, 257, 472-478.
44. Hollander-Jansen, M.; Dingemanse, J.; Langemeijer, M. W. E.; Danhof, M. Pharm. Res. 1989, 6, 585-591.
45. Richelson, E.; Nelson, A.; Neeper, R. J. Pharmacol. Exp. Ther. 1991, 256, 897-901.
46. Breimer, D. D.; Jochemsen, R.; Kamphuisen, H. A. C.; Nicholson, A. N.; Spencer, M. B.; Stone, B. M. Br. J. Clin. Pharmacol. 1985, 19, 807-815.
47. Robin, D. W.; MinHo, L.; Hasan, S. S.; Wood, J. J. A. Clin. Pharmacol. Ther. 1993, 54(6), 630-637.
48. Haigh, J. R. M.; Gent, J. P.; Garratt, J. C.; Pullar, T.; Feely, M. J. Neurol. Neurosurg. Psychiatr. 1988, 51, 1008-1009.